Company profile: Ambry Genetics
1.1 - Company Overview
Company description
- Provider of clinical genetic diagnostics and genetics software solutions, offering a comprehensive suite of genetic testing including clinical diagnostic exome sequencing, a proprietary ACMG-based variant classification scheme, family studies for co-segregation analysis, and +RNAinsight testing of up to 91 genes; benefiting 90% of U.S. patients covered by public and private insurers.
Products and services
- +RNAinsight: Ambry produces an RNA-based assay analyzing up to 91 genes, delivering additional data points that refine whether observed variants are benign or pathogenic
- Clinical Diagnostic Exome Sequencing: Ambry engineers a large-scale, clinical-grade exome testing system that identifies genetic variants, serving both diagnostic evaluation and discovery purposes in patient care
- Variant Classification Scheme: Ambry architects a proprietary, ACMG-compliant framework that classifies genetic variants using multidisciplinary expertise and all available evidence per ACMG guidelines
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ambry Genetics
PM Sleep Lab
HQ: United States
Website
- Description: Provider of medical facility services specializing in diagnosing and treating sleeping disorders, addressing conditions that affect driving, work and school performance, and relationships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PM Sleep Lab company profile →
Freedom Pathology
HQ: United States
Website
- Description: Provider of urology and gastroenterology diagnostic services, offering UTIDX, a urine-based PCR and antibiotic sensitivity test for urinary tract infections; Bladder17, a non-invasive urine test improving bladder cancer diagnosis; a Pre-Prostate Biopsy Rectal Swab to detect pathogens and antibiotic-resistant genes; and Prostatitis tests via post-massage urine/semen using PCR and sensitivity to guide treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Freedom Pathology company profile →
Life Molecular Imaging
HQ: Germany
Website
- Description: Provider of neuroimaging and cardiovascular molecular imaging services and PET tracers. Products include Neuraceq, a radioactive PET agent to estimate beta amyloid neuritic plaque density in adults with cognitive impairment; 18F-PI-2620 to image tau; 18F-florbetaben to detect amyloid deposits (under investigation for cardiac amyloidosis); and 18F-GP1 under investigation to detect acute thromboembolic events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Life Molecular Imaging company profile →
Viracor-IBT
HQ: United States
Website
- Description: Provider of specialty diagnostics laboratory services in allergy, immunology and infectious disease testing, delivering tests, results and support to doctors and hospitals to enable optimal care, and collaborating with pharmaceutical researchers to address complex challenges.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viracor-IBT company profile →
LMC Pathology Services
HQ: United States
Website
- Description: Provider of pathology and laboratory services, offering medical expertise and accessibility to cancer diagnostics, integrated diagnostics, and personalized medicine consultations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LMC Pathology Services company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ambry Genetics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ambry Genetics
2.2 - Growth funds investing in similar companies to Ambry Genetics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ambry Genetics
4.2 - Public trading comparable groups for Ambry Genetics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →